JPML Centralizes J&J Invokana Unit Litigation In N.J.
Law360, New York (December 9, 2016, 6:33 PM EST) -- Fifty-five lawsuits against a Johnson & Johnson unit over claims that the company failed to adequately test its Invokana diabetes drug and warn consumers about the risk of medical problems have been consolidated in New Jersey federal court under an order issued Wednesday by the U.S. Judicial Panel on Multidistrict Litigation.
The panel found that the actions against Janssen Pharmaceuticals Inc. involve common factual questions and that consolidating them would eliminate duplicative discovery, prevent inconsistent pretrial rulings, and conserve the resources of the parties, their counsel and the judiciary.
“The actions share factual questions arising from allegations that taking Invokana or...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!